Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

NCT06605378 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-03-03

No results posted yet for this study

Summary

This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.

Conditions

  • Chronic Granulomatous Disease (CGD)

Sponsors & Collaborators

  • Ensoma

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06605378 on ClinicalTrials.gov